- In March 2025, Medtronic plc announced the European launch of its next-generation Pipeline Vantage Embolization Device with Shield Technology, offering improved flow diversion for the treatment of complex brain aneurysms. The product emphasizes enhanced deliverability and reduced thrombogenicity, aligning with the market’s shift toward safer and more effective neurovascular devices.
- In November 2024, Stryker Corporation introduced its Trellis Neurothrombectomy System in select European countries, designed for rapid clot retrieval in ischemic stroke patients. The device integrates aspiration and mechanical thrombectomy, supporting faster recanalization and improved clinical outcomes.
- In August 2024, Penumbra, Inc. received CE mark approval for its RED Reperfusion Catheters in Europe, enabling broader access to advanced stroke intervention tools. The product's enhanced trackability and aspiration efficiency reflect increasing demand for precise and minimally invasive stroke therapies.
- In May 2024, MicroVention, Inc. (a Terumo company) expanded its SOFIA Flow Plus Catheter portfolio in Europe, enabling better access to distal neurovascular anatomy in stroke procedures. This development underscores the trend of device miniaturization and navigability in complex neurovascular interventions.
- In January 2024, Balt Group launched the Silk Vista Baby Flow Diverter across major European neurointerventional centers for the treatment of small and distal intracranial aneurysms. Its approval supports the growing need for specialized devices in treating anatomically challenging cerebrovascular conditions.
